Stempeutics Research Private Limited

Stempeutics Research Private Limited company information, Employees & Contact Information

Stempeutics is a leading Regenerative Medicine company in Bangalore with our patented stem-cell therapy platform technology developing treatment of cardiovascular, immune-mediated and degenerative diseases. The company's flagship product, Stempeucel® has received market authorization to treat Critical Limb Ischemia – a major unmet medical need in India. It is the FIRST innovative cell therapy based product to get marketing approval in India and Globally. CIPLA, the Indian licensee, has commenced pan-India commercialization. It has the FIRST DCGI approved Cell therapy product for Knee Osteoarthritis being marketed by Alkem. Stempeutics has a product in the Phase 3 stage covering Diabetic Foot Ulcer. Further it is conducting Phase 2 trial in Perianal fistula due to Crohn’s disease. Stempeucel® has strong patent protection with 20 patents granted including US, Europe and Japan. Stempeucel® has been classified as an Advanced Therapy Medicinal Product (ATMP) and designated as an Orphan Drug for the treatment of CLI due to Buerger’s Disease by the European Medicines Agency (EMA) Another portfolio developed by Stempeutics is Stempeucare® range of cosmetics. It is developed from the stem cell derived Growth Factors/Cytokines combination for various cosmetic and derma applications including rejuvenation of aging skin, hair fall control & hair growth promotion, under eye dark circle reduction cream etc. First product which has gone to the market is an intensive firming skin care cosmetic product, branded as Cutisera™. Other products ready for marketing are Trichosera™ for Hair application and Optisera™ for under eye application With a strong pipeline in Cell and Gene therapy products in some of the largest health and personal care segments like OTC Cosmetics (Skin and Hair Care), Osteoarthritis, Diabetes, CLI and PAF Stempeutics is poised to transform the Cell & Gene therapy space with its India First, Global Next approach.

Company Details

Employees
61
Founded
-
Address
3rd Floor, Manipal Hospitals Whitefield #143, Epip Industrial Area,itpl Main Road,whitefield,india
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Bangalore, Karnataka
Looking for a particular Stempeutics Research Private Limited employee's phone or email?

Stempeutics Research Private Limited Questions

News

MEDINET Japan, Stempeutics India ink deal for Stempeucel Cell Therapy for CLTI - ET Pharma

MEDINET Japan, Stempeutics India ink deal for Stempeucel Cell Therapy for CLTI ET Pharma

Stempeutics inks a first — formalises licensing deal with Japan’s Medinet, for stem cell product - BusinessLine

Stempeutics inks a first — formalises licensing deal with Japan’s Medinet, for stem cell product BusinessLine

MEDINET Japan Partners With Stempeutics India To Develop Stempeucel Cell Therapy For CLTI - BW Healthcare World

MEDINET Japan Partners With Stempeutics India To Develop Stempeucel Cell Therapy For CLTI BW Healthcare World

MEDINET Japan and Stempeutics India signs option license agreement for Stempeucel product - Express Healthcare

MEDINET Japan and Stempeutics India signs option license agreement for Stempeucel product Express Healthcare

MEDINET Japan and Stempeutics India sign option licence agreement for Stempeucel in Japan - Express Pharma

MEDINET Japan and Stempeutics India sign option licence agreement for Stempeucel in Japan Express Pharma

Stempeutics Receives Japan Process Patent for its Novel Stem Cell Drug 'Stempeucel®' - PR Newswire

Stempeutics Receives Japan Process Patent for its Novel Stem Cell Drug 'Stempeucel®' PR Newswire

India gives nod to cell therapy for Critical Limb Ischemia (CLI) - European Pharmaceutical Review

India gives nod to cell therapy for Critical Limb Ischemia (CLI) European Pharmaceutical Review

India’s first stem cell drug Stempeucel to hit market by fiscal end - Mint

India’s first stem cell drug Stempeucel to hit market by fiscal end Mint

Stempeutics completes patient enrollment for Phase 3 of cell therapy trial for DFU - Deccan Chronicle

Stempeutics completes patient enrollment for Phase 3 of cell therapy trial for DFU Deccan Chronicle

DCGI Gives Limited Approval to Market FIRST Allogeneic cell Therapy Product in India Stempeutics puts India on the 'World map of Regenerative Medicine' - PR Newswire

DCGI Gives Limited Approval to Market FIRST Allogeneic cell Therapy Product in India Stempeutics puts India on the 'World map of Regenerative Medicine' PR Newswire

US patent to Stempeutics for Stempeucel for treating critical limb ischemia - Healthcare Radius

US patent to Stempeutics for Stempeucel for treating critical limb ischemia Healthcare Radius

Manipal Group-backed Stempeutics bags first of its kind stem cell treatment deal in Japan - Moneycontrol

Manipal Group-backed Stempeutics bags first of its kind stem cell treatment deal in Japan Moneycontrol

Stempeutics gets EMA approval to market stem cell drug in EU - The Economic Times

Stempeutics gets EMA approval to market stem cell drug in EU The Economic Times

Alkem, Stempeutics Launch Cell Therapy ‘StemOne’ For Knee Osteoarthritis - BW Healthcare World

Alkem, Stempeutics Launch Cell Therapy ‘StemOne’ For Knee Osteoarthritis BW Healthcare World

Manipal Group’s Stempeutics Research raises ₹95 cr from Kemwell Biopharma - Mint

Manipal Group’s Stempeutics Research raises ₹95 cr from Kemwell Biopharma Mint

Alkem, in partnership with Stempeutics, launches stem cell therapy to treat knee osteoarthritis - Express Pharma

Alkem, in partnership with Stempeutics, launches stem cell therapy to treat knee osteoarthritis Express Pharma

Alkem and Stempeutics launch StemOne for treatment of knee osteoarthritis - ET HealthWorld

Alkem and Stempeutics launch StemOne for treatment of knee osteoarthritis ET HealthWorld

Stempeutics gets process patent from Japan for stem cell-based drug - Mint

Stempeutics gets process patent from Japan for stem cell-based drug Mint

Stempeutics gets EU process patent for drug Stempeucel - Mint

Stempeutics gets EU process patent for drug Stempeucel Mint

Cipla partner Stempeutics gets DCGI nod for stem cell-based product - Business Standard

Cipla partner Stempeutics gets DCGI nod for stem cell-based product Business Standard

Stempeutics' allogeneic cell therapy gets DCGI approval, Cipla to market and distribute Stempeucel - Express Pharma

Stempeutics' allogeneic cell therapy gets DCGI approval, Cipla to market and distribute Stempeucel Express Pharma

Alkem Labs launches off-the-shelf cell therapy StemOne for knee joint diseases - financialexpress.com

Alkem Labs launches off-the-shelf cell therapy StemOne for knee joint diseases financialexpress.com

Stempeutics out licenses its novel stem cell product ‘Stempeucel-DFU’ to Cipla for treating non healing diabetic foot ulcer - Healthcare Radius

Stempeutics out licenses its novel stem cell product ‘Stempeucel-DFU’ to Cipla for treating non healing diabetic foot ulcer Healthcare Radius

India's first off-the-shelf cell therapy treatment for knee osteoarthritis - Business Standard

India's first off-the-shelf cell therapy treatment for knee osteoarthritis Business Standard

A single-shot option for osteoarthritis now available from the Stempeutics-Alkem collaboration - BusinessLine

A single-shot option for osteoarthritis now available from the Stempeutics-Alkem collaboration BusinessLine

Stempeutics out licenses its stem cell product to Cipla for treating Diabetic Foot Ulcer - Express Pharma

Stempeutics out licenses its stem cell product to Cipla for treating Diabetic Foot Ulcer Express Pharma

Stempeutics eyes late-stage trial waiver for stem-cell drug - Mint

Stempeutics eyes late-stage trial waiver for stem-cell drug Mint

This India-made stem-cell treatment drug will be sold in Japan - NewsBytes

This India-made stem-cell treatment drug will be sold in Japan NewsBytes

Top Stempeutics Research Private Limited Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant